TRML

COM:TOURMALINEBIO

Tourmaline Bio, Inc.

  • Stock

Last Close

24.00

21/11 17:18

Market Cap

352.13M

Beta: -

Volume Today

70.09K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
asset turnover
cash per share
20.74
-
0.41
98.04%
company equity multiplier
-0.66
-
-0.46
30.53%
days of inventory outstanding
days of payables outstanding
113.66
-
24.39K
21,362.46%
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
1
-
1
0%
effective tax rate
52.22K
-
enterprise value multiple
-35.47
-
-10.14
71.41%
fixed asset turnover
free cash flow per share
-3.90
-
-0.57
85.47%
gross profit margin
interest coverage
inventory turnover
long term debt to capitalization
-0.02
-
net income per ebt
1
-
1
0%
net profit margin
operating cash flow per share
-3.68
-
-0.32
91.36%
operating profit margin
payables turnover
3.21
-
0.01
99.53%
pretax profit margin
price fair value
-7.36K
-
-10.51
99.86%
receivables turnover
return on assets
-0.01
-
-2.17
35,830.66%
return on capital employed
0.00
-
-2.55
63,774.85%
return on equity
0.00
-
1.00
24,860.72%
total debt to capitalization
-1.97
-
-0.03
98.67%

All numbers in (except ratios and percentages)